Johnson And Johnson Coronavirus Vaccine
- All
- News
- Videos
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
J&J Vaccine Gets Additional Warning On Bleeding Side Effect
The fact sheet for Johnson & Johnson's Covid-19 vaccine has been revised by U.S. regulators to warn of the risk of a rare bleeding disorder.
-
Boris Johnson On "Best" Single Defence Against Covid Variant Omicron
Booster COVID-19 vaccines increase the body's immune response and remain the best single defence against the new Omicron variant of coronavirus, British Prime Minister Boris Johnson said on Tuesday.
-
US Panel Recommends Johnson & Johnson Vaccine Booster With 2-Month Gap
A high level panel of US medical experts voted unanimously Friday to recommend authorizing a second shot of the Johnson & Johnson Covid vaccine.
-
Johnson & Johnson Asks US To Authorise Booster Shots Of Covid Vaccine
Drug maker Johnson & Johnson asked the US Food and Drug Administration (FDA) on Tuesday to authorize booster shots of its Covid-19 vaccine for people over the age of 18.
-
Johnson & Johnson Seeks Nod For Vaccine Trials For 12-17 Group In India
Johnson & Johnson has applied for permission to conduct COVID-19 vaccine trials in India on children in the 12-17 age group, saying it is critical that "all sections of the population" are vaccinated to ensure achievement of herd immunity status.
-
Still In Talks With India Over COVID-19 Vaccine: Johnson & Johnson
India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details, according to a report by news agency Reuters.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
France Recognises Covishield For Vaccine Pass, Tightens Travel Rules
France will consider people fully vaccinated one week after they received their second dose of the Pfizer/BioNTech, Moderna and AstraZeneca shots, instead of 14 days previously, and 28 days after their Johnson & Johnson jab.
-
J&J Says Its Vaccine Gives At Least 8-Month Immunity For Delta Variant
Johnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly.
-
British PM Boris Johnson Hints At Unrestricted Travel For Fully Vaccinated People
British Prime Minister Boris Johnson hinted on Thursday that the UK was close to permitting unrestricted travel abroad for fully vaccinated people, in what would be a huge boost for airlines and holiday companies brought to their knees by COVID-19.
-
South Africa Pulls 2 Million Johnson & Johnson Covid Vaccine Doses
South Africa, which is struggling to roll out its inoculation programme as it enters a third wave of the coronavirus pandemic, said Sunday it will pull two million of doses Johnson & Johnson vaccine.
-
UK Approves Single Shot Johnson & Johnson Covid Vaccine
Britain on Friday approved the use of a the single shot Johnson & Johnson coronavirus vaccine, the Medicines and Healthcare products Regulatory Agency (MHRA) announced Friday.
-
Centre Looking Into Securing Part Of J&J Vaccine Shots For India: Report
J&J's COVID-19 vaccine, to be manufactured in India by Biological E, will have to be handed over entirely to the US pharma giant as agreed but the government is looking at the possibility of securing a part of this production, sources said.
-
Belgium Limits Johnson & Johnson Jab To Over-41s After Post-Vaccine Death
Johnson & Johnson's single-jab vaccine against COVID-19 will be limited in Belgium to people aged 41 and over, authorities said on Wednesday following the death of a woman who received the jab.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
J&J Vaccine Gets Additional Warning On Bleeding Side Effect
The fact sheet for Johnson & Johnson's Covid-19 vaccine has been revised by U.S. regulators to warn of the risk of a rare bleeding disorder.
-
Boris Johnson On "Best" Single Defence Against Covid Variant Omicron
Booster COVID-19 vaccines increase the body's immune response and remain the best single defence against the new Omicron variant of coronavirus, British Prime Minister Boris Johnson said on Tuesday.
-
US Panel Recommends Johnson & Johnson Vaccine Booster With 2-Month Gap
A high level panel of US medical experts voted unanimously Friday to recommend authorizing a second shot of the Johnson & Johnson Covid vaccine.
-
Johnson & Johnson Asks US To Authorise Booster Shots Of Covid Vaccine
Drug maker Johnson & Johnson asked the US Food and Drug Administration (FDA) on Tuesday to authorize booster shots of its Covid-19 vaccine for people over the age of 18.
-
Johnson & Johnson Seeks Nod For Vaccine Trials For 12-17 Group In India
Johnson & Johnson has applied for permission to conduct COVID-19 vaccine trials in India on children in the 12-17 age group, saying it is critical that "all sections of the population" are vaccinated to ensure achievement of herd immunity status.
-
Still In Talks With India Over COVID-19 Vaccine: Johnson & Johnson
India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details, according to a report by news agency Reuters.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
France Recognises Covishield For Vaccine Pass, Tightens Travel Rules
France will consider people fully vaccinated one week after they received their second dose of the Pfizer/BioNTech, Moderna and AstraZeneca shots, instead of 14 days previously, and 28 days after their Johnson & Johnson jab.
-
J&J Says Its Vaccine Gives At Least 8-Month Immunity For Delta Variant
Johnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly.
-
British PM Boris Johnson Hints At Unrestricted Travel For Fully Vaccinated People
British Prime Minister Boris Johnson hinted on Thursday that the UK was close to permitting unrestricted travel abroad for fully vaccinated people, in what would be a huge boost for airlines and holiday companies brought to their knees by COVID-19.
-
South Africa Pulls 2 Million Johnson & Johnson Covid Vaccine Doses
South Africa, which is struggling to roll out its inoculation programme as it enters a third wave of the coronavirus pandemic, said Sunday it will pull two million of doses Johnson & Johnson vaccine.
-
UK Approves Single Shot Johnson & Johnson Covid Vaccine
Britain on Friday approved the use of a the single shot Johnson & Johnson coronavirus vaccine, the Medicines and Healthcare products Regulatory Agency (MHRA) announced Friday.
-
Centre Looking Into Securing Part Of J&J Vaccine Shots For India: Report
J&J's COVID-19 vaccine, to be manufactured in India by Biological E, will have to be handed over entirely to the US pharma giant as agreed but the government is looking at the possibility of securing a part of this production, sources said.
-
Belgium Limits Johnson & Johnson Jab To Over-41s After Post-Vaccine Death
Johnson & Johnson's single-jab vaccine against COVID-19 will be limited in Belgium to people aged 41 and over, authorities said on Wednesday following the death of a woman who received the jab.
